Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome.

Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome.
复制标题

DOI:
10.1007/s10549-009-0571-2
复制
发表时间:
2010-07
影响因子:
3.8
通讯作者:
Lipkowitz, Stanley
Lipkowitz, Stanley
中科院分区:
医学2区
文献类型:
--
作者:
Murrow, Lyndsay M.;Garimella, Sireesha V.;Jones, Tamara L.;Caplen, Natasha J.;Lipkowitz, Stanley

文献摘要

参考文献

被引文献

相似文献

乳腺癌可分为表达雌激素(ER)和孕激素(PR)受体的乳腺癌,具有ERBB 2(HER-2/Neu)扩增的乳腺癌,以及不表达ER、PR或ERBB 2扩增的乳腺癌(称为三阴性或基底样乳腺癌)。为了确定乳腺癌中潜在的分子靶点,我们对人酪氨酸激酶组进行了合成siRNA介导的RNAi筛选。在三阴性/基底样乳腺癌细胞系MDA-MB 231中进行的初步RNAi筛选,随后在该细胞系和另外两种三阴性/基底样乳腺癌细胞系BT 20和HCC 1937中进行的二次RNAi筛选和进一步研究,鉴定了G2/M检查点蛋白WEE 1作为潜在的治疗靶标。在所有乳腺癌亚型的细胞系中观察到对WEE 1抑制的相似敏感性。在乳腺癌细胞系中,RNAi介导的WEE 1沉默或小化合物抑制导致γ H2 AX水平增加,细胞周期S期停滞,细胞增殖显著降低。WEE 1抑制的细胞发生凋亡,如通过阳性膜联蛋白V染色、亚G1 DNA含量增加、凋亡形态、半胱天冬酶激活和泛半胱天冬酶抑制剂Z-VAD-FMK的拯救所证明的。相反,非转化的乳腺上皮细胞系MCF 10A在WEE 1沉默或抑制后没有表现出任何这些下游效应。这些结果确定WEE 1作为乳腺癌的潜在分子靶点。
Breast cancers can be classified into those that express the estrogen (ER) and progesterone (PR) receptors, those with ERBB2 (HER-2/Neu) amplification, and those without expression of ER, PR, or amplification of ERBB2 (referred to as triple-negative or basal-like breast cancer). In order to identify potential molecular targets in breast cancer, we performed a synthetic siRNA-mediated RNAi screen of the human tyrosine kinome. A primary RNAi screen conducted in the triple-negative/basal-like breast cancer cell line MDA-MB231 followed by secondary RNAi screens and further studies in this cell line and two additional triple-negative/basal-like breast cancer cell lines, BT20 and HCC1937, identified the G2/M checkpoint protein, WEE1, as a potential therapeutic target. Similar sensitivity to WEE1 inhibition was observed in cell lines from all subtypes of breast cancer. RNAi-mediated silencing or small compound inhibition of WEE1 in breast cancer cell lines resulted in an increase in γH2AX levels, arrest in the S-phase of the cell cycle, and a significant decrease in cell proliferation. WEE1-inhibited cells underwent apoptosis as demonstrated by positive Annexin V staining, increased sub-G1 DNA content, apoptotic morphology, caspase activation, and rescue by the pan-caspase inhibitor, Z-VAD-FMK. In contrast, the non-transformed mammary epithelial cell line, MCF10A, did not exhibit any of these downstream effects following WEE1 silencing or inhibition. These results identify WEE1 as a potential molecular target in breast cancer.
DOI: 10.1007/s10549-008-9924-5
发表时间: 2009-01-01
影响因子: 3.8
作者:
Rahman, Monzur;Davis, Sean R.;Lipkowitz, Stanley
通讯作者: Lipkowitz, Stanley
DOI: 10.1667/0033-7587(2002)157
发表时间: 2002-03-01
期刊: RADIATION RESEARCH
影响因子: 3.4
作者:
Johnston, CJ;Williams, JP;Finkelstein, JN
通讯作者: Finkelstein, JN
DOI: 10.1016/j.ccr.2006.10.008
发表时间: 2006-12-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Neve, Richard M.;Chin, Koei;Gray, Joe W.
通讯作者: Gray, Joe W.
DOI: 10.1002/humu.20495
发表时间: 2007-06-01
期刊: HUMAN MUTATION
影响因子: 3.9
作者:
Petitjean, Audrey;Mathe, Ewy;Olivier, Magali
通讯作者: Olivier, Magali
DOI: 10.1038/ncb1258
发表时间: 2005-06-01
影响因子: 21.3
作者:
MacKeigan, JP;Murphy, LO;Blenis, J
通讯作者: Blenis, J